This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$24.21
US$ Class I Dist
NAV per share 31.03.2020
£406.6mAUM

AUM 28.02.2020

Holdings
69.16% Active Share
As at 28.02.2020